Martin Koller
Plus aucun poste en cours
Profil
Martin Koller formerly worked at Wyeth LLC, as Principal, Athena Neurosciences LLC, as Vice President-Clinical Development, Elan Pharmaceuticals, LLC, as Vice President-Clinical Development from 2002 to 2007, Sonexa Therapeutics, Inc., as Chief Medical Officer from 2009 to 2013, Syntex, Inc., as Principal, and Prothena Corp.
Plc, as Chief Medical Officer from 2013 to 2017.
Dr. Koller received his graduate degree from The University of Texas at Austin, undergraduate degree from Franklin & Marshall College, and doctorate degree from the University of Maryland Baltimore County.
Anciens postes connus de Martin Koller
| Sociétés | Poste | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Directeur Technique/Scientifique/R&D | 17/05/2017 |
Sonexa Therapeutics, Inc.
 Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2007 |
| Syntex, Inc. | Corporate Officer/Principal | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Formation de Martin Koller
| The University of Texas at Austin | Graduate Degree |
| Franklin & Marshall College | Undergraduate Degree |
| University of Maryland Baltimore County | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Health Technology |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Syntex, Inc. | Miscellaneous |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
